ReviewBMC cancer2023

Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib.

Kensuke Kanaoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.